APA (7th ed.) Citation

Zhong, Z., Liang, W., Dai, Y., Xue, C., Zhou, D., Xu, Z., . . . Ye, Q. (2026). HepAssis2® bioartificial liver system in treating acute‐on‐chronic liver failure patients: Findings from a phase 1 randomised, open‐label clinical trial. Clinical & Translational Medicine, 16(2), 1. https://doi.org/10.1002/ctm2.70620

Chicago Style (17th ed.) Citation

Zhong, Zibiao, et al. "HepAssis2® Bioartificial Liver System in Treating Acute‐on‐chronic Liver Failure Patients: Findings from a Phase 1 Randomised, Open‐label Clinical Trial." Clinical & Translational Medicine 16, no. 2 (2026): 1. https://doi.org/10.1002/ctm2.70620.

MLA (9th ed.) Citation

Zhong, Zibiao, et al. "HepAssis2® Bioartificial Liver System in Treating Acute‐on‐chronic Liver Failure Patients: Findings from a Phase 1 Randomised, Open‐label Clinical Trial." Clinical & Translational Medicine, vol. 16, no. 2, 2026, p. 1, https://doi.org/10.1002/ctm2.70620.